Please see the table below for the list of Industry companies from whom we received contributions and revenue in 2022:
|
Name |
Amount (USD) |
Percent of Gross Revenue |
|---|---|---|
|
4D Molecular Therapeutics, Inc. |
14,800.00 |
0.01% |
|
AbbVie |
652,481.78 |
0.49% |
|
Aceragen |
3,800.00 |
0.00% |
|
Alcresta Therapeutics, Inc. |
15,000.00 |
0.01% |
|
Altis Biosystems |
5,800.00 |
0.00% |
|
Arcturus Therapeutics, Inc. |
8,615.00 |
0.00% |
|
Aridis Pharmaceuticals Inc. |
21,000.00 |
0.02% |
|
Arrevus Inc. |
5,000.00 |
0.00% |
|
BiomX |
5,000.00 |
0.00% |
|
Boehringer Ingelheim |
21,000.00 |
0.02% |
|
Calithera Biosciences, Inc |
8,000.00 |
0.01% |
|
Callion Pharma |
5,500.00 |
0.00% |
|
Catalent |
40.00 |
0.00% |
|
Chiesi |
34,000.00 |
0.03% |
|
CVS |
3,800.00 |
0.00% |
|
Eli Lilly |
2,615.00 |
0.00% |
|
ELITechGroup Biomedical System |
5,500.00 |
0.00% |
|
Eloxx Pharmaceuticals |
2,000.00 |
0.00% |
|
Enterprise Therapeutics Limited |
5,000.00 |
0.00% |
|
Genentech |
149,037.50 |
0.11% |
|
Gilead |
352,125.00 |
0.26% |
|
GlaxoSmithKlein |
15,214.38 |
0.01% |
|
Hill-Rom |
2,800.00 |
0.00% |
|
Horizon Therapeutics |
1,251.25 |
0.00% |
|
Illumina, Inc. |
1,212.50 |
0.00% |
|
Insmed Incorporated |
1,872,108.33 |
1.40% |
|
Janssen Pharmaceuticals |
10,000.00 |
0.01% |
|
Johnson & Johnson |
100.00 |
0.00% |
|
Monaghan Medical Corporation |
7,000.00 |
0.01% |
|
Mylan |
245,000.00 |
0.18% |
|
Nabriva Therapeutics |
7,000.00 |
0.01% |
|
Nestle Health Science |
200.00 |
0.00% |
|
Novartis |
5,245.79 |
0.00% |
|
Optum Specialty Pharmacy |
1,249.75 |
0.00% |
|
PARI Respiratory Equipment |
8,500.00 |
0.01% |
|
Pfizer |
23,335.25 |
0.02% |
|
ReCode Therapeutics |
3,850.00 |
0.00% |
|
RespirTech |
14,550.00 |
0.01% |
|
Rho Inc. |
9,000.00 |
0.01% |
|
Sangamo Therapeutics |
100.00 |
0.00% |
|
Sound Pharmaceuticals |
6,500.00 |
0.00% |
|
Spirovant Sciences, Inc. |
10,000.00 |
0.01% |
|
Synspira Therapeutics, LLC |
5,000.00 |
0.00% |
|
Translate Bio |
850.00 |
0.00% |
|
Vertex* |
5,773,205.34 |
4.31% |
|
Viatris |
756.89 |
0.00% |
|
VIVUS, Inc. |
13,930.00 |
0.01% |
|
Walgreens Specialty Pharmacy |
89,664.69 |
0.07% |
|
Zephyrx |
5,500.00 |
0.00% |
*This amount includes $5 million in licensing revenue for access to clinical care-based data, compliant with patient informed consents.
